Zentrum für Neuropathologie und Prionforschung
print

Sprachumschaltung

Navigationspfad


Inhaltsbereich

Dr. med. Thomas Arzberger

[2019] [2018] [2017] [2016] [2015] [2014] [2013] [2012] [2011] [2010] [2009] [2008] [2007] [2006] [2005] [2004] [2003] [2002] [2001] [2000] [1999] [1998] [1997] [1996] [1995] [1994] [1992]

2019

Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Höglinger GU & Movement Disorder Society-endorsed PSP Study Group
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society, 2019 Mar 18

Yin C, Ackermann S, Ma Z, Mohanta SK, Zhang C, Li Y, Nietzsche S, Westermann M, Peng L, Hu D, Bontha SV, Srikakulapu P, Beer M, Megens RTA, Steffens S, Hildner M, Halder LD, Eckstein HH, Pelisek J, Herms J, Roeber S, Arzberger T, Borodovsky A, Habenicht L, Binder CJ, Weber C, Zipfel PF, Skerka C & Habenicht AJR
ApoE attenuates unresolvable inflammation by complex formation with activated C1q.
Nature medicine, 2019 Mar, 25 (3) 496-506

Midani-Kurçak JS, Dinekov M, Puladi B, Arzberger T & Köhler C
Effect of tau-pathology on charged multivesicular body protein 2b (CHMP2B).
Brain research, 2019 Mar 01, 1706 224-236

Yin C, Ackermann S, Ma Z, Mohanta SK, Zhang C, Li Y, Nietzsche S, Westermann M, Peng L, Hu D, Bontha SV, Srikakulapu P, Beer M, Megens RTA, Steffens S, Hildner M, Halder LD, Eckstein HH, Pelisek J, Herms J, Roeber S, Arzberger T, Borodovsky A, Habenicht L, Binder CJ, Weber C, Zipfel PF, Skerka C & Habenicht AJR
Publisher Correction: ApoE attenuates unresolvable inflammation by complex formation with activated C1q.
Nature medicine, 2019 Mar, 25 (3) 529

Pottier C, Ren Y, Perkerson RB, Baker M, Jenkins GD, van Blitterswijk M, DeJesus-Hernandez M, van Rooij JGJ, Murray ME, Christopher E, McDonnell SK, Fogarty Z, Batzler A, Tian S, Vicente CT, Matchett B, Karydas AM, Hsiung GR, Seelaar H, Mol MO, Finger EC, Graff C, Öijerstedt L, Neumann M, Heutink P, Synofzik M, Wilke C, Prudlo J, Rizzu P, Simon-Sanchez J, Edbauer D, Roeber S, Diehl-Schmid J, Evers BM, King A, Mesulam MM, Weintraub S, Geula C, Bieniek KF, Petrucelli L, Ahern GL, Reiman EM, Woodruff BK, Caselli RJ, Huey ED, Farlow MR, Grafman J, Mead S, Grinberg LT, Spina S, Grossman M, Irwin DJ, Lee EB, Suh E, Snowden J, Mann D, Ertekin-Taner N, Uitti RJ, Wszolek ZK, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Hodges JR, Piguet O, Geier EG, Yokoyama JS, Rissman RA, Rogaeva E, Keith J, Zinman L, Tartaglia MC, Cairns NJ, Cruchaga C, Ghetti B, Kofler J, Lopez OL, Beach TG, Arzberger T, Herms J, Honig LS, Vonsattel JP, Halliday GM, Kwok JB, White CL, Gearing M, Glass J, Rollinson S, Pickering-Brown S, Rohrer JD, Trojanowski JQ, Van Deerlin V, Bigio EH, Troakes C, Al-Sarraj S, Asmann Y, Miller BL, Graff-Radford NR, Boeve BF, Seeley WW, Mackenzie IRA, van Swieten JC, Dickson DW, Biernacka JM & Rademakers R
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.
Acta neuropathologica, 2019 Feb 09

Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N, Krasemann S, Lichtenthaler SF, Müller SA, Colombo A, Monasor LS, Tahirovic S, Herms J, Willem M, Pettkus N, Butovsky O, Bartenstein P, Edbauer D, Rominger A, Ertürk A, Grathwohl SA, Neher JJ, Holtzman DM, Meyer-Luehmann M & Haass C
Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE.
Nature neuroscience, 2019 Feb, 22 (2) 191-204

2018

Pihlstrøm L, Schottlaender L, Chelban V, Houlden H, MSA Exome Consortium & Arzberger T
LRP10 in α-synucleinopathies.
The Lancet. Neurology, 2018 Dec, 17 (12) 1033-1034

Bartoletti-Stella A, Corrado P, Mometto N, Baiardi S, Durrenberger PF, Arzberger T, Reynolds R, Kretzschmar H, Capellari S & Parchi P
Analysis of RNA Expression Profiles Identifies Dysregulated Vesicle Trafficking Pathways in Creutzfeldt-Jakob Disease.
Molecular neurobiology, 2018 Nov 16

Zellner A, Scharrer E, Arzberger T, Oka C, Domenga-Denier V, Joutel A, Lichtenthaler SF, Müller SA, Dichgans M & Haffner C
CADASIL brain vessels show a HTRA1 loss-of-function profile.
Acta neuropathologica, 2018 Jul, 136 (1) 111-125

Hartmann H, Hornburg D, Czuppa M, Bader J, Michaelsen M, Farny D, Arzberger T, Mann M, Meissner F & Edbauer D
Proteomics and C9orf72 neuropathology identify ribosomes as poly-GR/PR interactors driving toxicity.
Life science alliance, 2018 May, 1 (2) e201800070

Liu J, Heinsen H, Grinberg LT, Alho E, Amaro E, Pasqualucci CA, Rüb U, Seidel K, den Dunnen W, Arzberger T, Schmitz C, Kiessling MC, Bader B & Danek A
Pathoarchitectonics of the cerebral cortex in chorea-acanthocytosis and Huntington's disease.
Neuropathology and applied neurobiology, 2018 May 02

Schrötter A, Oberhaus A, Kolbe K, Seger S, Mastalski T, El Magraoui F, Hoffmann-Posorske E, Bohnert M, Deckert J, Braun C, Graw M, Schmitz C, Arzberger T, Loosse C, Heinsen H, Meyer HE & Müller T
Corrigendum to "LMD proteomics provides evidence for hippocampus field-specific motor protein abundance changes with relevance to Alzheimer's disease" [BBAPAP 1865 (6) (2017) 703-714].
Biochimica et biophysica acta. Proteins and proteomics, 2018 Apr, 1866 (4) 580

Liu J, Heinsen H, Grinberg LT, Alho E, Amaro E, Pasqualucci CA, Rüb U, den Dunnen W, Arzberger T, Schmitz C, Kiessling M, Bader B & Danek A
Subcortical neurodegeneration in chorea: Similarities and differences between chorea-acanthocytosis and Huntington's disease.
Parkinsonism & related disorders, 2018 Apr, 49 54-59

Weber A, Schwarz SC, Tost J, Trümbach D, Winter P, Busato F, Tacik P, Windhorst AC, Fagny M, Arzberger T, McLean C, van Swieten JC, Schwarz J, Vogt Weisenhorn D, Wurst W, Adhikary T, Dickson DW, Höglinger GU & Müller U
Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1.
Nature communications, 2018 Jul 26, 9 (1) 2929

Gasparoni G, Bultmann S, Lutsik P, Kraus TFJ, Sordon S, Vlcek J, Dietinger V, Steinmaurer M, Haider M, Mulholland CB, Arzberger T, Roeber S, Riemenschneider M, Kretzschmar HA, Giese A, Leonhardt H & Walter J
DNA methylation analysis on purified neurons and glia dissects age and Alzheimer's disease-specific changes in the human cortex.
Epigenetics & chromatin, 2018 Jul 25, 11 (1) 41

Schönecker S, Neuhofer C, Otto M, Ludolph A, Kassubek J, Landwehrmeyer B, Anderl-Straub S, Semler E, Diehl-Schmid J, Prix C, Vollmar C, Fortea J, Deutsches FTLD-Konsortium, Huppertz HJ, Arzberger T, Edbauer D, Feddersen B, Dieterich M, Schroeter ML, Volk AE, Fließbach K, Schneider A, Kornhuber J, Maler M, Prudlo J, Jahn H, Boeckh-Behrens T, Danek A, Klopstock T & Levin J
Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients - An Atlas-Based Volumetric MRI Study.
Frontiers in aging neuroscience, 2018, 10 45

Arzberger T, Schludi MH, Lehmer C, Schmid B & Edbauer D
RNA versus protein toxicity in C9orf72 ALS/FTLD.
Acta neuropathologica, 2018 Mar, 135 (3) 475-479

2017

Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Whitwell JL, Antonini A, Bhatia KP, Bordelon Y, Corvol JC, Colosimo C, Dodel R, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris H, Nestor P, Oertel WH, Rabinovici GD, Rowe JB, van Eimeren T, Wenning GK, Boxer A, Golbe LI, Litvan I, Stamelou M, Höglinger GU & Movement Disorder Society-Endorsed PSP Study Group
Which ante mortem clinical features predict progressive supranuclear palsy pathology?
Movement disorders : official journal of the Movement Disorder Society, 2017 Jul, 32 (7) 995-1005

Schrötter A, Oberhaus A, Kolbe K, Seger S, Mastalski T, El Magraoui F, Hoffmann-Posorske E, Bohnert M, Deckert J, Braun C, Graw M, Schmitz C, Arzberger T, Loosse C, Heinsen H, Meyer HE & Müller T
LMD proteomics provides evidence for hippocampus field-specific motor protein abundance changes with relevance to Alzheimer's disease.
Biochimica et biophysica acta. Proteins and proteomics, 2017 Jun, 1865 (6) 703-714

Bürger K, Arzberger T, Stephan J, Levin J & Edbauer D
[Pathomechanisms and clinical aspects of frontotemporal lobar degeneration].
Der Nervenarzt, 2017 Feb, 88 (2) 163-172

Llovera G, Benakis C, Enzmann G, Cai R, Arzberger T, Ghasemigharagoz A, Mao X, Malik R, Lazarevic I, Liebscher S, Ertürk A, Meissner L, Vivien D, Haffner C, Plesnila N, Montaner J, Engelhardt B & Liesz A
The choroid plexus is a key cerebral invasion route for T cells after stroke.
Acta neuropathologica, 2017 Dec, 134 (6) 851-868

Schludi MH, Becker L, Garrett L, Gendron TF, Zhou Q, Schreiber F, Popper B, Dimou L, Strom TM, Winkelmann J, von Thaden A, Rentzsch K, May S, Michaelsen M, Schwenk BM, Tan J, Schoser B, Dieterich M, Petrucelli L, Hölter SM, Wurst W, Fuchs H, Gailus-Durner V, de Angelis MH, Klopstock T, Arzberger T & Edbauer D
Spinal poly-GA inclusions in a C9orf72 mouse model trigger motor deficits and inflammation without neuron loss.
Acta neuropathologica, 2017 Aug, 134 (2) 241-254

Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I & Movement Disorder Society-endorsed PSP Study Group
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
Movement disorders : official journal of the Movement Disorder Society, 2017 Jun, 32 (6) 853-864

Lehmer C, Oeckl P, Weishaupt JH, Volk AE, Diehl-Schmid J, Schroeter ML, Lauer M, Kornhuber J, Levin J, Fassbender K, Landwehrmeyer B, German Consortium for Frontotemporal Lobar Degeneration, Schludi MH, Arzberger T, Kremmer E, Flatley A, Feederle R, Steinacker P, Weydt P, Ludolph AC, Edbauer D & Otto M
Poly-GP in cerebrospinal fluid links C9orf72-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD.
EMBO molecular medicine, 2017 Jul, 9 (7) 859-868

Zhou Q, Lehmer C, Michaelsen M, Mori K, Alterauge D, Baumjohann D, Schludi MH, Greiling J, Farny D, Flatley A, Feederle R, May S, Schreiber F, Arzberger T, Kuhm C, Klopstock T, Hermann A, Haass C & Edbauer D
Antibodies inhibit transmission and aggregation of C9orf72 poly-GA dipeptide repeat proteins.
EMBO molecular medicine, 2017 May, 9 (5) 687-702

Bruch J, Xu H, Rösler TW, De Andrade A, Kuhn PH, Lichtenthaler SF, Arzberger T, Winklhofer KF, Müller U & Höglinger GU
PERK activation mitigates tau pathology in vitro and in vivo.
EMBO molecular medicine, 2017 Mar, 9 (3) 371-384

Kleinberger G, Brendel M, Mracsko E, Wefers B, Groeneweg L, Xiang X, Focke C, Deußing M, Suárez-Calvet M, Mazaheri F, Parhizkar S, Pettkus N, Wurst W, Feederle R, Bartenstein P, Mueggler T, Arzberger T, Knuesel I, Rominger A & Haass C
The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism.
The EMBO journal, 2017 Jul 03, 36 (13) 1837-1853

2016

Suárez-Calvet M, Neumann M, Arzberger T, Abou-Ajram C, Funk E, Hartmann H, Edbauer D, Kremmer E, Göbl C, Resch M, Bourgeois B, Madl T, Reber S, Jutzi D, Ruepp MD, Mackenzie IR, Ansorge O, Dormann D & Haass C
Monomethylated and unmethylated FUS exhibit increased binding to Transportin and distinguish FTLD-FUS from ALS-FUS.
Acta neuropathologica, 2016 Apr, 131 (4) 587-604

Levin J, Kurz A, Arzberger T, Giese A & Höglinger GU
The Differential Diagnosis and Treatment of Atypical Parkinsonism.
Deutsches Arzteblatt international, 2016 Feb 05, 113 (5) 61-9

Liu J, Wang LN, Arzberger T & Zhu MW
Pathological Changes of von Economo Neuron and Fork Neuron in Neuropsychiatric Diseases.
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae, 2016 Feb, 38 (1) 113-7

Kurz C, Ebersbach G, Respondek G, Giese A, Arzberger T & Höglinger GU
An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.
Acta neuropathologica communications, 2016 Nov 14, 4 (1) 120

Tatura R, Kraus T, Giese A, Arzberger T, Buchholz M, Höglinger G & Müller U
Parkinson's disease: SNCA-, PARK2-, and LRRK2- targeting microRNAs elevated in cingulate gyrus.
Parkinsonism & related disorders, 2016 Dec, 33 115-121

Herring A, Münster Y, Akkaya T, Moghaddam S, Deinsberger K, Meyer J, Zahel J, Sanchez-Mendoza E, Wang Y, Hermann DM, Arzberger T, Teuber-Hanselmann S & Keyvani K
Kallikrein-8 inhibition attenuates Alzheimer's disease pathology in mice.
Alzheimer's & dementia : the journal of the Alzheimer's Association, 2016 Dec, 12 (12) 1273-1287

Kretner B, Trambauer J, Fukumori A, Mielke J, Kuhn PH, Kremmer E, Giese A, Lichtenthaler SF, Haass C, Arzberger T & Steiner H
Generation and deposition of Aβ43 by the virtually inactive presenilin-1 L435F mutant contradicts the presenilin loss-of-function hypothesis of Alzheimer's disease.
EMBO molecular medicine, 2016 May, 8 (5) 458-65

Mori K, Nihei Y, Arzberger T, Zhou Q, Mackenzie IR, Hermann A, Hanisch F, German Consortium for Frontotemporal Lobar Degeneration, Bavarian Brain Banking Alliance, Kamp F, Nuscher B, Orozco D, Edbauer D & Haass C
Reduced hnRNPA3 increases C9orf72 repeat RNA levels and dipeptide-repeat protein deposition.
EMBO reports, 2016 Sep, 17 (9) 1314-25

Schwenk BM, Hartmann H, Serdaroglu A, Schludi MH, Hornburg D, Meissner F, Orozco D, Colombo A, Tahirovic S, Michaelsen M, Schreiber F, Haupt S, Peitz M, Brüstle O, Küpper C, Klopstock T, Otto M, Ludolph AC, Arzberger T, Kuhn PH & Edbauer D
TDP-43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons.
The EMBO journal, 2016 Nov 02, 35 (21) 2350-2370

Müller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, Soto-Ortolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Dion PA, Wurster I, Shulman JM, Srulijes K, Haubenberger D, Pastor P, Vilariño-Güell C, Postuma RB, Bernard G, Ladwig KH, Dupré N, Jankovic J, Strauch K, Panisset M, Winkelmann J, Testa CM, Reischl E, Zeuner KE, Ross OA, Arzberger T, Chouinard S, Deuschl G, Louis ED, Kuhlenbäumer G & Rouleau GA
Genome-wide association study in essential tremor identifies three new loci.
Brain : a journal of neurology, 2016 Dec, 139 (Pt 12) 3163-3169

Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, Murray ME, Nelson PT, Takahashi H, Trojanowski JQ, Ansorge O, Arzberger T, Baborie A, Beach TG, Bieniek KF, Bigio EH, Bodi I, Dugger BN, Feany M, Gelpi E, Gentleman SM, Giaccone G, Hatanpaa KJ, Heale R, Hof PR, Hofer M, Hortobágyi T, Jellinger K, Jicha GA, Ince P, Kofler J, Kövari E, Kril JJ, Mann DM, Matej R, McKee AC, McLean C, Milenkovic I, Montine TJ, Murayama S, Lee EB, Rahimi J, Rodriguez RD, Rozemüller A, Schneider JA, Schultz C, Seeley W, Seilhean D, Smith C, Tagliavini F, Takao M, Thal DR, Toledo JB, Tolnay M, Troncoso JC, Vinters HV, Weis S, Wharton SB, White CL, Wisniewski T, Woulfe JM, Yamada M & Dickson DW
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.
Acta neuropathologica, 2016 Jan, 131 (1) 87-102

2015

Roeber S, Müller-Sarnowski F, Kress J, Edbauer D, Kuhlmann T, Tüttelmann F, Schindler C, Winter P, Arzberger T, Müller U, Danek A & Kretzschmar HA
Three novel presenilin 1 mutations marking the wide spectrum of age at onset and clinical patterns in familial Alzheimer's disease.
Journal of neural transmission (Vienna, Austria : 1996), 2015 Dec, 122 (12) 1715-9

Levin J, Bak TH, Rominger A, Mille E, Arzberger T, Giese A, Ackl N, Lorenzl S, Bader B, Patzig M, Bötzel K & Danek A
The association of aphasia and right-sided motor impairment in corticobasal syndrome.
Journal of neurology, 2015 Oct, 262 (10) 2241-6

Schludi MH, May S, Grässer FA, Rentzsch K, Kremmer E, Küpper C, Klopstock T, German Consortium for Frontotemporal Lobar Degeneration, Bavarian Brain Banking Alliance, Arzberger T & Edbauer D
Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing.
Acta neuropathologica, 2015 Oct, 130 (4) 537-55

Schulte EC, Fukumori A, Mollenhauer B, Hor H, Arzberger T, Perneczky R, Kurz A, Diehl-Schmid J, Hüll M, Lichtner P, Eckstein G, Zimprich A, Haubenberger D, Pirker W, Brücke T, Bereznai B, Molnar MJ, Lorenzo-Betancor O, Pastor P, Peters A, Gieger C, Estivill X, Meitinger T, Kretzschmar HA, Trenkwalder C, Haass C & Winkelmann J
Rare variants in β-Amyloid precursor protein (APP) and Parkinson's disease.
European journal of human genetics : EJHG, 2015 Oct, 23 (10) 1328-33

Schludi MH, May S, Grässer FA, Rentzsch K, Kremmer E, Küpper C, Klopstock T, German Consortium for Frontotemporal Lobar Degeneration, Bavarian Brain Banking Alliance, Arzberger T & Edbauer D
Erratum to: Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing.
Acta neuropathologica, 2015 Oct, 130 (4) 557-8

Bruch J, Kurz C, Vasiljevic A, Nicolino M, Arzberger T & Höglinger GU
Early Neurodegeneration in the Brain of a Child Without Functional PKR-like Endoplasmic Reticulum Kinase.
Journal of neuropathology and experimental neurology, 2015 Aug, 74 (8) 850-7

Meyronet D, Dorey A, Massoma P, Rey C, Alix E, Silva K, Perrin C, Quadrio I, Perret-Liaudet A, Streichenberger N, Thomasset N, Honnorat J, Arzberger T & Kretzschmar H
The workflow from post-mortem human brain sampling to cell microdissection: a Brain Net Europe study.
Journal of neural transmission (Vienna, Austria : 1996), 2015 Jul, 122 (7) 975-91

Strobel S, Grünblatt E, Riederer P, Heinsen H, Arzberger T, Al-Sarraj S, Troakes C, Ferrer I & Monoranu CM
Changes in the expression of genes related to neuroinflammation over the course of sporadic Alzheimer's disease progression: CX3CL1, TREM2, and PPARγ.
Journal of neural transmission (Vienna, Austria : 1996), 2015 Jul, 122 (7) 1069-76

Klioueva NM, Rademaker MC, Dexter DT, Al-Sarraj S, Seilhean D, Streichenberger N, Schmitz P, Bell JE, Ironside JW, Arzberger T & Huitinga I
BrainNet Europe's Code of Conduct for brain banking.
Journal of neural transmission (Vienna, Austria : 1996), 2015 Jul, 122 (7) 937-40

Thal DR, von Arnim CA, Griffin WS, Mrak RE, Walker L, Attems J & Arzberger T
Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies.
Journal of neural transmission (Vienna, Austria : 1996), 2015 Jul, 122 (7) 1007-18

Alafuzoff I, Pikkarainen M, Neumann M, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Ince PG, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Revesz T, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB & Kretzschmar H
Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.
Journal of neural transmission (Vienna, Austria : 1996), 2015 Jul, 122 (7) 957-72

Durrenberger PF, Fernando FS, Kashefi SN, Bonnert TP, Seilhean D, Nait-Oumesmar B, Schmitt A, Gebicke-Haerter PJ, Falkai P, Grünblatt E, Palkovits M, Arzberger T, Kretzschmar H, Dexter DT & Reynolds R
Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.
Journal of neural transmission (Vienna, Austria : 1996), 2015 Jul, 122 (7) 1055-68

Edbauer D & Arzberger T
Brain banks still yield high interest rates.
Journal of neural transmission (Vienna, Austria : 1996), 2015 Jul, 122 (7) 935-6

Giese A & Arzberger T
In Memoriam: Hans A. Kretzschmar (1953–2014).
Journal of neural transmission (Vienna, Austria : 1996), 2015 Jul, 122 (7) 934-5

Alafuzoff I, Pikkarainen M, Neumann M, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Ince PG, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Revesz T, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB & Kretzschmar H
Erratum to: Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium.
Journal of neural transmission (Vienna, Austria : 1996), 2015 Jul, 122 (7) 973-4

Yousefi BH, Manook A, Grimmer T, Arzberger T, von Reutern B, Henriksen G, Drzezga A, Förster S, Schwaiger M & Wester HJ
Characterization and first human investigation of FIBT, a novel fluorinated Aβ plaque neuroimaging PET radioligand.
ACS chemical neuroscience, 2015 Mar 18, 6 (3) 428-37

Liu J, Zhu MW, Arzberger T & Wang LN
Frontotemporal Lobar Degeneration with Accumulation of Argyrophilic Grains and Lewy Bodies: A Clinicopathological Report.
Journal of Alzheimer's disease : JAD, 2015, 48 (1) 55-8

Zhu MW, Liu J, Arzberger T, Wang LN & Wang ZF
Typical or atypical progressive supranuclear palsy: a comparative clinicopathologic study of three Chinese cases.
International journal of clinical and experimental pathology, 2015, 8 (1) 867-74

2014

Respondek G, Stamelou M, Kurz C, Ferguson LW, Rajput A, Chiu WZ, van Swieten JC, Troakes C, Al Sarraj S, Gelpi E, Gaig C, Tolosa E, Oertel WH, Giese A, Roeber S, Arzberger T, Wagenpfeil S, Höglinger GU & Movement Disorder Society-endorsed PSP Study Group
The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.
Movement disorders : official journal of the Movement Disorder Society, 2014 Dec, 29 (14) 1758-66

May S, Hornburg D, Schludi MH, Arzberger T, Rentzsch K, Schwenk BM, Grässer FA, Mori K, Kremmer E, Banzhaf-Strathmann J, Mann M, Meissner F & Edbauer D
C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration.
Acta neuropathologica, 2014 Oct, 128 (4) 485-503

Banzhaf-Strathmann J, Benito E, May S, Arzberger T, Tahirovic S, Kretzschmar H, Fischer A & Edbauer D
MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease.
The EMBO journal, 2014 Aug 01, 33 (15) 1667-80

Levin J, Tiedt S, Arzberger T, Biskup S, Schuberth M, Stenglein-Krapf G, Kreth FW, Högen T, la Fougère C, Linn J, van der Knaap MS, Giese A, Kretzschmar HA & Danek A
Diffuse leukoencephalopathy with spheroids: biopsy findings and a novel mutation.
Clinical neurology and neurosurgery, 2014 Jul, 122 113-5

Sellmann C, Villarín Pildaín L, Schmitt A, Leonardi-Essmann F, Durrenberger PF, Spanagel R, Arzberger T, Kretzschmar H, Zink M, Gruber O, Herrera-Marschitz M, Reynolds R, Falkai P, Gebicke-Haerter PJ & Matthäus F
Gene expression in superior temporal cortex of schizophrenia patients.
European archives of psychiatry and clinical neuroscience, 2014 Jun, 264 (4) 297-309

Schuberth M, Levin J, Sawalhe D, Schwarzkopf R, von Baumgarten L, Ertl-Wagner B, Rominger A, Arzberger T, Kretzschmar HA, Froböse T, Diehl-Schmid J, Biskup S & Danek A
[Hereditary diffuse leukencephalopathy with spheroids: a microgliopathy due to CSF1 receptor impairment].
Der Nervenarzt, 2014 Apr, 85 (4) 465-70

Götzl JK, Mori K, Damme M, Fellerer K, Tahirovic S, Kleinberger G, Janssens J, van der Zee J, Lang CM, Kremmer E, Martin JJ, Engelborghs S, Kretzschmar HA, Arzberger T, Van Broeckhoven C, Haass C & Capell A
Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis.
Acta neuropathologica, 2014, 127 (6) 845-60

Gerschütz A, Heinsen H, Grünblatt E, Wagner AK, Bartl J, Meissner C, Fallgatter AJ, Al-Sarraj S, Troakes C, Ferrer I, Arzberger T, Deckert J, Riederer P, Fischer M, Tatschner T & Monoranu CM
Neuron-specific alterations in signal transduction pathways associated with Alzheimer's disease.
Journal of Alzheimer's disease : JAD, 2014, 40 (1) 135-42

Schottlaender LV, Houlden H, Multiple-System Atrophy (MSA) Brain Bank Collaboration & Arzberger T
Mutant COQ2 in multiple-system atrophy.
The New England journal of medicine, 2014 Jul 03, 371 (1) 81

2013

Gerschütz A, Heinsen H, Grünblatt E, Wagner AK, Bartl J, Meissner C, Fallgatter AJ, Al-Sarraj S, Troakes C, Ferrer I, Arzberger T, Deckert J, Riederer P, Fischer M, Tatschner T & Monoranu CM
Neuron-specific mitochondrial DNA deletion levels in sporadic Alzheimer's disease.
Current Alzheimer research, 2013 Dec, 10 (10) 1041-6

Mori K, Arzberger T, Grässer FA, Gijselinck I, May S, Rentzsch K, Weng SM, Schludi MH, van der Zee J, Cruts M, Van Broeckhoven C, Kremmer E, Kretzschmar HA, Haass C & Edbauer D
Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins.
Acta neuropathologica, 2013 Dec, 126 (6) 881-93

Mackenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K, Weng SM, Haass C, Kretzschmar HA, Edbauer D & Neumann M
Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations.
Acta neuropathologica, 2013 Dec, 126 (6) 859-79

Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, Haass C & Edbauer D
The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.
Science (New York, N.Y.), 2013 Mar 15, 339 (6125) 1335-8

Mori K, Lammich S, Mackenzie IR, Forné I, Zilow S, Kretzschmar H, Edbauer D, Janssens J, Kleinberger G, Cruts M, Herms J, Neumann M, Van Broeckhoven C, Arzberger T & Haass C
hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations.
Acta neuropathologica, 2013 Mar, 125 (3) 413-23

Kovacs GG, Rozemuller AJ, van Swieten JC, Gelpi E, Majtenyi K, Al-Sarraj S, Troakes C, Bódi I, King A, Hortobágyi T, Esiri MM, Ansorge O, Giaccone G, Ferrer I, Arzberger T, Bogdanovic N, Nilsson T, Leisser I, Alafuzoff I, Ironside JW, Kretzschmar H & Budka H
Neuropathology of the hippocampus in FTLD-Tau with Pick bodies: a study of the BrainNet Europe Consortium.
Neuropathology and applied neurobiology, 2013 Feb, 39 (2) 166-78

Honarnejad K, Jung CK, Lammich S, Arzberger T, Kretzschmar H & Herms J
Involvement of presenilin holoprotein upregulation in calcium dyshomeostasis of Alzheimer's disease.
Journal of cellular and molecular medicine, 2013 Feb, 17 (2) 293-302

van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Engelborghs S, Philtjens S, Vandenbulcke M, Sleegers K, Sieben A, Bäumer V, Maes G, Corsmit E, Borroni B, Padovani A, Archetti S, Perneczky R, Diehl-Schmid J, de Mendonça A, Miltenberger-Miltenyi G, Pereira S, Pimentel J, Nacmias B, Bagnoli S, Sorbi S, Graff C, Chiang HH, Westerlund M, Sanchez-Valle R, Llado A, Gelpi E, Santana I, Almeida MR, Santiago B, Frisoni G, Zanetti O, Bonvicini C, Synofzik M, Maetzler W, Vom Hagen JM, Schöls L, Heneka MT, Jessen F, Matej R, Parobkova E, Kovacs GG, Ströbel T, Sarafov S, Tournev I, Jordanova A, Danek A, Arzberger T, Fabrizi GM, Testi S, Salmon E, Santens P, Martin JJ, Cras P, Vandenberghe R, De Deyn PP, Cruts M, Van Broeckhoven C, van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Theuns J, Philtjens S, Sleegers K, Bäumer V, Maes G, Corsmit E, Cruts M, Van Broeckhoven C, van der Zee J, Gijselinck I, Dillen L, Van Langenhove T, Philtjens S, Theuns J, Sleegers K, Bäumer V, Maes G, Cruts M, Van Broeckhoven C, Engelborghs S, De Deyn PP, Cras P, Engelborghs S, De Deyn PP, Vandenbulcke M, Vandenbulcke M, Borroni B, Padovani A, Archetti S, Perneczky R, Diehl-Schmid J, Synofzik M, Maetzler W, Müller Vom Hagen J, Schöls L, Synofzik M, Maetzler W, Müller Vom Hagen J, Schöls L, Heneka MT, Jessen F, Ramirez A, Kurzwelly D, Sachtleben C, Mairer W, de Mendonça A, Miltenberger-Miltenyi G, Pereira S, Firmo C, Pimentel J, Sanchez-Valle R, Llado A, Antonell A, Molinuevo J, Gelpi E, Graff C, Chiang HH, Westerlund M, Graff C, Kinhult Ståhlbom A, Thonberg H, Nennesmo I, Börjesson-Hanson A, Nacmias B, Bagnoli S, Sorbi S, Bessi V, Piaceri I, Santana I, Santiago B, Santana I, Helena Ribeiro M, Rosário Almeida M, Oliveira C, Massano J, Garret C, Pires P, Frisoni G, Zanetti O, Bonvicini C, Sarafov S, Tournev I, Jordanova A, Tournev I, Kovacs GG, Ströbel T, Heneka MT, Jessen F, Ramirez A, Kurzwelly D, Sachtleben C, Mairer W, Jessen F, Matej R, Parobkova E, Danel A, Arzberger T, Maria Fabrizi G, Testi S, Ferrari S, Cavallaro T, Salmon E, Santens P, Cras P & European Early-Onset Dementia Consortium
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.
Human mutation, 2013 Feb, 34 (2) 363-73

2012

Durrenberger PF, Fernando FS, Magliozzi R, Kashefi SN, Bonnert TP, Ferrer I, Seilhean D, Nait-Oumesmar B, Schmitt A, Gebicke-Haerter PJ, Falkai P, Grünblatt E, Palkovits M, Parchi P, Capellari S, Arzberger T, Kretzschmar H, Roncaroli F, Dexter DT & Reynolds R
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study.
Acta neuropathologica, 2012 Dec, 124 (6) 893-903

Schankin CJ, Reifferscheid AK, Krumbholz M, Linn J, Rachinger W, Langer S, Sostak P, Arzberger T, Kretzschmar H & Straube A
Headache in patients with pituitary adenoma: clinical and paraclinical findings.
Cephalalgia : an international journal of headache, 2012 Dec, 32 (16) 1198-207

Alafuzoff I, Gelpi E, Al-Sarraj S, Arzberger T, Attems J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Englund E, Ferrer I, Gentleman S, Giaccone G, Graeber MB, Hortobagyi T, Höftberger R, Ironside JW, Jellinger K, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Rozemuller A, Seilhean D, Streichenberger N, Thal DR, Wharton SB & Kretzschmar H
The need to unify neuropathological assessments of vascular alterations in the ageing brain: multicentre survey by the BrainNet Europe consortium.
Experimental gerontology, 2012 Nov, 47 (11) 825-33

Schmitt A, Leonardi-Essmann F, Durrenberger PF, Wichert SP, Spanagel R, Arzberger T, Kretzschmar H, Zink M, Herrera-Marschitz M, Reynolds R, Rossner MJ, Falkai P & Gebicke-Haerter PJ
Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients.
European archives of psychiatry and clinical neuroscience, 2012 Oct, 262 (7) 565-77

Eisele S, Krumbholz M, Fischer MT, Mohan H, Junker A, Arzberger T, Hohlfeld R, Bradl M, Lassmann H & Meinl E
Prospects of transcript profiling for mRNAs and MicroRNAs using formalin-fixed and paraffin-embedded dissected autoptic multiple sclerosis lesions.
Brain pathology (Zurich, Switzerland), 2012 Sep, 22 (5) 607-18

Ottis P, Koppe K, Onisko B, Dynin I, Arzberger T, Kretzschmar H, Requena JR, Silva CJ, Huston JP & Korth C
Human and rat brain lipofuscin proteome.
Proteomics, 2012 Aug, 12 (15-16) 2445-54

Lin MT, Cantuti-Castelvetri I, Zheng K, Jackson KE, Tan YB, Arzberger T, Lees AJ, Betensky RA, Beal MF & Simon DK
Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease.
Annals of neurology, 2012 Jun, 71 (6) 850-4

Schön C, Hoffmann NA, Ochs SM, Burgold S, Filser S, Steinbach S, Seeliger MW, Arzberger T, Goedert M, Kretzschmar HA, Schmidt B & Herms J
Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice.
PloS one, 2012, 7 (12) e53547

2011

Oberländer U, Pletinckx K, Döhler A, Müller N, Lutz MB, Arzberger T, Riederer P, Gerlach M, Koutsilieri E & Scheller C
Neuromelanin is an immune stimulator for dendritic cells in vitro.
BMC neuroscience, 2011 Nov 15, 12 116

Schmitt A, Leonardi-Essmann F, Durrenberger PF, Parlapani E, Schneider-Axmann T, Spanagel R, Arzberger T, Kretzschmar H, Herrera-Marschitz M, Gruber O, Reynolds R, Falkai P & Gebicke-Haerter PJ
Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2011 Apr, 12 (3) 201-15

Giaccone G, Arzberger T, Alafuzoff I, Al-Sarraj S, Budka H, Duyckaerts C, Falkai P, Ferrer I, Ironside JW, Kovács GG, Meyronet D, Parchi P, Patsouris E, Revesz T, Riederer P, Rozemuller A, Schmitt A, Winblad B, Kretzschmar H & BrainNet Europe consortium
New lexicon and criteria for the diagnosis of Alzheimer's disease.
The Lancet. Neurology, 2011 Apr, 10 (4) 298-9; author reply 300-1

2010

Berg D, Godau J, Riederer P, Gerlach M & Arzberger T
Microglia activation is related to substantia nigra echogenicity.
Journal of neural transmission (Vienna, Austria : 1996), 2010 Nov, 117 (11) 1287-92

Zausinger S, Schoeller K, Arzberger T & Muacevic A
Combined surgical and radiosurgical treatment of symptomatic aggressive vertebral osteomyelitis.
Minimally invasive neurosurgery : MIN, 2010 Apr, 53 (2) 80-2

Durrenberger PF, Fernando S, Kashefi SN, Ferrer I, Hauw JJ, Seilhean D, Smith C, Walker R, Al-Sarraj S, Troakes C, Palkovits M, Kasztner M, Huitinga I, Arzberger T, Dexter DT, Kretzschmar H & Reynolds R
Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study.
Journal of neuropathology and experimental neurology, 2010 Jan, 69 (1) 70-81

2009

Theodoropoulou M, Tichomirowa MA, Sievers C, Yassouridis A, Arzberger T, Hougrand O, Deprez M, Daly AF, Petrossians P, Pagotto U, Beckers A & Stalla GK
Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegaly.
International journal of cancer, 2009 Nov 01, 125 (9) 2122-6

Tribl F, Asan E, Arzberger T, Tatschner T, Langenfeld E, Meyer HE, Bringmann G, Riederer P, Gerlach M & Marcus K
Identification of L-ferritin in neuromelanin granules of the human substantia nigra: a targeted proteomics approach.
Molecular & cellular proteomics : MCP, 2009 Aug, 8 (8) 1832-8

Alafuzoff I, Ince PG, Arzberger T, Al-Sarraj S, Bell J, Bodi I, Bogdanovic N, Bugiani O, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Parchi P, Parkkinen L, Patsouris E, Roggendorf W, Rozemuller A, Stadelmann-Nessler C, Streichenberger N, Thal DR & Kretzschmar H
Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.
Acta neuropathologica, 2009 Jun, 117 (6) 635-52

Alafuzoff I, Thal DR, Arzberger T, Bogdanovic N, Al-Sarraj S, Bodi I, Boluda S, Bugiani O, Duyckaerts C, Gelpi E, Gentleman S, Giaccone G, Graeber M, Hortobagyi T, Höftberger R, Ince P, Ironside JW, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Nilsson T, Parchi P, Patsouris E, Pikkarainen M, Revesz T, Rozemuller A, Seilhean D, Schulz-Schaeffer W, Streichenberger N, Wharton SB & Kretzschmar H
Assessment of beta-amyloid deposits in human brain: a study of the BrainNet Europe Consortium.
Acta neuropathologica, 2009 Mar, 117 (3) 309-20

2008

Alafuzoff I, Arzberger T, Al-Sarraj S, Bodi I, Bogdanovic N, Braak H, Bugiani O, Del-Tredici K, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Ince P, Kamphorst W, King A, Korkolopoulou P, Kovács GG, Larionov S, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Tagliavini F, Stadelmann C, Streichenberger N, Thal DR, Wharton SB & Kretzschmar H
Staging of neurofibrillary pathology in Alzheimer's disease: a study of the BrainNet Europe Consortium.
Brain pathology (Zurich, Switzerland), 2008 Oct, 18 (4) 484-96

Roeber S, Grasbon-Frodl EM, Windl O, Krebs B, Xiang W, Vollmert C, Illig T, Schröter A, Arzberger T, Weber P, Zerr I & Kretzschmar HA
Evidence for a pathogenic role of different mutations at codon 188 of PRNP.
PloS one, 2008 May 14, 3 (5) e2147

Bell JE, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Budka H, Dexter DT, Falkai P, Ferrer I, Gelpi E, Gentleman SM, Giaccone G, Huitinga I, Ironside JW, Klioueva N, Kovacs GG, Meyronet D, Palkovits M, Parchi P, Patsouris E, Reynolds R, Riederer P, Roggendorf W, Seilhean D, Schmitt A, Schmitz P, Streichenberger N, Schwalber A & Kretzschmar H
Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.
Acta neuropathologica, 2008 May, 115 (5) 497-507

Alafuzoff I, Pikkarainen M, Arzberger T, Thal DR, Al-Sarraj S, Bell J, Bodi I, Budka H, Capetillo-Zarate E, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kavantzas N, King A, Korkolopoulou P, Kovács GG, Meyronet D, Monoranu C, Parchi P, Patsouris E, Roggendorf W, Stadelmann C, Streichenberger N, Tagliavini F & Kretzschmar H
Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium.
Acta neuropathologica, 2008 May, 115 (5) 533-46

Crecelius A, Götz A, Arzberger T, Fröhlich T, Arnold GJ, Ferrer I & Kretzschmar HA
Assessing quantitative post-mortem changes in the gray matter of the human frontal cortex proteome by 2-D DIGE.
Proteomics, 2008 Mar, 8 (6) 1276-91

Alafuzoff I, Parkkinen L, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Ferrer I, Gelpi E, Gentleman S, Giaccone G, Kamphorst W, King A, Korkolopoulou P, Kovács GG, Larionov S, Meyronet D, Monoranu C, Morris J, Parchi P, Patsouris E, Roggendorf W, Seilhean D, Streichenberger N, Thal DR, Kretzschmar H & BrainNet Europe Consortium
Assessment of alpha-synuclein pathology: a study of the BrainNet Europe Consortium.
Journal of neuropathology and experimental neurology, 2008 Feb, 67 (2) 125-43

Kovacs GG, Alafuzoff I, Al-Sarraj S, Arzberger T, Bogdanovic N, Capellari S, Ferrer I, Gelpi E, Kövari V, Kretzschmar H, Nagy Z, Parchi P, Seilhean D, Soininen H, Troakes C & Budka H
Mixed brain pathologies in dementia: the BrainNet Europe consortium experience.
Dementia and geriatric cognitive disorders, 2008, 26 (4) 343-50

Friedrich M, Körte R, Portero C, Arzberger T, Kretzschmar HA, Zerr I & Nacimiento W
[Fatal familial insomnia--a rare differential diagnosis in dementia].
Fortschritte der Neurologie-Psychiatrie, 2008 Jan, 76 (1) 36-40

2007

Grünblatt E, Zander N, Bartl J, Jie L, Monoranu CM, Arzberger T, Ravid R, Roggendorf W, Gerlach M & Riederer P
Comparison analysis of gene expression patterns between sporadic Alzheimer's and Parkinson's disease.
Journal of Alzheimer's disease : JAD, 2007 Dec, 12 (4) 291-311

Krumbholz M, Theil D, Steinmeyer F, Cepok S, Hemmer B, Hofbauer M, Farina C, Derfuss T, Junker A, Arzberger T, Sinicina I, Hartle C, Newcombe J, Hohlfeld R & Meinl E
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions.
Journal of neuroimmunology, 2007 Oct, 190 (1-2) 72-9

Scharpf M, Schweizer U, Arzberger T, Roggendorf W, Schomburg L & Köhrle J
Neuronal and ependymal expression of selenoprotein P in the human brain.
Journal of neural transmission (Vienna, Austria : 1996), 2007 Jul, 114 (7) 877-84

Ferrer I, Armstrong J, Capellari S, Parchi P, Arzberger T, Bell J, Budka H, Ströbel T, Giaccone G, Rossi G, Bogdanovic N, Fakai P, Schmitt A, Riederers P, Al-Sarraj S, Ravid R & Kretzschmar H
Effects of formalin fixation, paraffin embedding, and time of storage on DNA preservation in brain tissue: a BrainNet Europe study.
Brain pathology (Zurich, Switzerland), 2007 Jul, 17 (3) 297-303

Jacob CP, Koutsilieri E, Bartl J, Neuen-Jacob E, Arzberger T, Zander N, Ravid R, Roggendorf W, Riederer P & Grünblatt E
Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease.
Journal of Alzheimer's disease : JAD, 2007 Mar, 11 (1) 97-116

Tribl F, Arzberger T, Riederer P & Gerlach M
Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis.
Journal of neural transmission. Supplementum, 2007, (72) 51-5

Schmitt A, Bauer M, Heinsen H, Feiden W, Consortium of Brainnet Europe II, Falkai P, Alafuzoff I, Arzberger T, Al-Sarraj S, Bell JE, Bogdanovic N, Brück W, Budka H, Ferrer I, Giaccone G, Kovacs GG, Meyronet D, Palkovits M, Parchi P, Patsouris E, Ravid R, Reynolds R, Riederer P, Roggendorf W, Schwalber A, Seilhean D & Kretzschmar H
How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II.
Journal of neural transmission (Vienna, Austria : 1996), 2007, 114 (5) 527-37

Ferrer I, Santpere G, Arzberger T, Bell J, Blanco R, Boluda S, Budka H, Carmona M, Giaccone G, Krebs B, Limido L, Parchi P, Puig B, Strammiello R, Ströbel T & Kretzschmar H
Brain protein preservation largely depends on the postmortem storage temperature: implications for study of proteins in human neurologic diseases and management of brain banks: a BrainNet Europe Study.
Journal of neuropathology and experimental neurology, 2007 Jan, 66 (1) 35-46

2006

Braak H, Alafuzoff I, Arzberger T, Kretzschmar H & Del Tredici K
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.
Acta neuropathologica, 2006 Oct, 112 (4) 389-404

Fröhlich T, Helmstetter D, Zobawa M, Crecelius AC, Arzberger T, Kretzschmar HA & Arnold GJ
Analysis of the HUPO Brain Proteome reference samples using 2-D DIGE and 2-D LC-MS/MS.
Proteomics, 2006 Sep, 6 (18) 4950-66

Alafuzoff I, Pikkarainen M, Al-Sarraj S, Arzberger T, Bell J, Bodi I, Bogdanovic N, Budka H, Bugiani O, Ferrer I, Gelpi E, Giaccone G, Graeber MB, Hauw JJ, Kamphorst W, King A, Kopp N, Korkolopoulou P, Kovács GG, Meyronet D, Parchi P, Patsouris E, Preusser M, Ravid R, Roggendorf W, Seilhean D, Streichenberger N, Thal DR & Kretzschmar H
Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium.
Journal of neuropathology and experimental neurology, 2006 Aug, 65 (8) 740-57

2005

Zecca L, Berg D, Arzberger T, Ruprecht P, Rausch WD, Musicco M, Tampellini D, Riederer P, Gerlach M & Becker G
In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
Movement disorders : official journal of the Movement Disorder Society, 2005 Oct, 20 (10) 1278-85

Tribl F, Gerlach M, Marcus K, Asan E, Tatschner T, Arzberger T, Meyer HE, Bringmann G & Riederer P
"Subcellular proteomics" of neuromelanin granules isolated from the human brain.
Molecular & cellular proteomics : MCP, 2005 Jul, 4 (7) 945-57

Perron H, Lazarini F, Ruprecht K, Péchoux-Longin C, Seilhean D, Sazdovitch V, Créange A, Battail-Poirot N, Sibaï G, Santoro L, Jolivet M, Darlix JL, Rieckmann P, Arzberger T, Hauw JJ & Lassmann H
Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions.
Journal of neurovirology, 2005 Feb, 11 (1) 23-33

2004

Theodoropoulou M, Arzberger T, Gruebler Y, Jaffrain-Rea ML, Schlegel J, Schaaf L, Petrangeli E, Losa M, Stalla GK & Pagotto U
Expression of epidermal growth factor receptor in neoplastic pituitary cells: evidence for a role in corticotropinoma cells.
The Journal of endocrinology, 2004 Nov, 183 (2) 385-94

Theodoropoulou M, Cavallari I, Barzon L, D'Agostino DM, Ferro T, Arzberger T, Grübler Y, Schaaf L, Losa M, Fallo F, Ciminale V, Stalla GK & Pagotto U
Differential expression of menin in sporadic pituitary adenomas.
Endocrine-related cancer, 2004 Jun, 11 (2) 333-44

Dzierzega-Lecznar A, Kurkiewicz S, Stepien K, Chodurek E, Wilczok T, Arzberger T, Riederer P & Gerlach M
GC/MS analysis of thermally degraded neuromelanin from the human substantia nigra.
Journal of the American Society for Mass Spectrometry, 2004 Jun, 15 (6) 920-6

2003

Gerlach M, Double K, Arzberger T, Leblhuber F, Tatschner T & Riederer P
Dopamine receptor agonists in current clinical use: comparative dopamine receptor binding profiles defined in the human striatum.
Journal of neural transmission (Vienna, Austria : 1996), 2003 Oct, 110 (10) 1119-27

2002

Ubl A, Berg D, Holzmann C, Krüger R, Berger K, Arzberger T, Bornemann A & Riess O
14-3-3 protein is a component of Lewy bodies in Parkinson's disease-mutation analysis and association studies of 14-3-3 eta.
Brain research. Molecular brain research, 2002 Dec, 108 (1-2) 33-9

Petri S, Krampfl K, Dengler R, Bufler J, Weindl A & Arzberger T
Human GABA A receptors on dopaminergic neurons in the pars compacta of the substantia nigra.
The Journal of comparative neurology, 2002 Oct 28, 452 (4) 360-6

Hansen IA, Jakob O, Wortmann S, Arzberger T, Allolio B & Blind E
Characterization of the human and mouse genes encoding the tuberoinfundibular peptide of 39 residues, a ligand of the parathyroid hormone receptor family.
The Journal of endocrinology, 2002 Jul, 174 (1) 95-102

Lange M, Pagotto U, Renner U, Arzberger T, Oeckler R & Stalla GK
The role of endothelins in the regulation of pituitary function.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2002 May, 110 (3) 103-12

Winkelmann J, Pagotto U, Theodoropoulou M, Tatsch K, Saeger W, Müller A, Arzberger T, Schaaf L, Schumann EM, Trenkwalder C & Stalla GK
Retention of dopamine 2 receptor mRNA and absence of the protein in craniospinal and extracranial metastasis of a malignant prolactinoma: a case report.
European journal of endocrinology, 2002 Jan, 146 (1) 81-8

2001

Pagotto U, Marsicano G, Fezza F, Theodoropoulou M, Grübler Y, Stalla J, Arzberger T, Milone A, Losa M, Di Marzo V, Lutz B & Stalla GK
Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level.
The Journal of clinical endocrinology and metabolism, 2001 Jun, 86 (6) 2687-96

2000

Pagotto U, Arzberger T, Theodoropoulou M, Grübler Y, Pantaloni C, Saeger W, Losa M, Journot L, Stalla GK & Spengler D
The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas.
Cancer research, 2000 Dec 15, 60 (24) 6794-9

Theodoropoulou M, Arzberger T, Gruebler Y, Korali Z, Mortini P, Joba W, Heufelder AE, Stalla GK & Schaaf L
Thyrotrophin receptor protein expression in normal and adenomatous human pituitary.
The Journal of endocrinology, 2000 Oct, 167 (1) 7-13

1999

Heim C, Arzberger T, Sontag T, Xiao A, Herbinger KH, Weindl A & Sontag KH
Progressive degeneration of dopamine system functions after transient cerebral oligemia in rats.
Brain research, 1999 Dec 18, 851 (1-2) 235-46

Pagotto U, Arzberger T, Ciani E, Lezoualc'h F, Pilon C, Journot L, Spengler D & Stalla GK
Inhibition of Zac1, a new gene differentially expressed in the anterior pituitary, increases cell proliferation.
Endocrinology, 1999 Feb, 140 (2) 987-96

1998

Renner U, Arzberger T, Pagotto U, Leimgruber S, Uhl E, Müller A, Lange M, Weindl A & Stalla GK
Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically nonfunctioning pituitary adenomas.
The Journal of clinical endocrinology and metabolism, 1998 Apr, 83 (4) 1368-75

1997

Arzberger T, Krampfl K, Leimgruber S & Weindl A
Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease--an in situ hybridization study.
Journal of neuropathology and experimental neurology, 1997 Apr, 56 (4) 440-54

1996

Quasthoff S, Adelsberger H, Grosskreutz J, Arzberger T & Schröder JM
Immunohistochemical and electrophysiological evidence for omega-conotoxin-sensitive calcium channels in unmyelinated C-fibres of biopsied human sural nerve.
Brain research, 1996 Jun 03, 723 (1-2) 29-36

Jahn K, Bufler J, Weindl A, Arzberger T & Hatt H
Patch-clamp study on membrane properties and transmitter activated currents of rabbit area postrema neurons.
Journal of comparative physiology. A, Sensory, neural, and behavioral physiology, 1996 Jun, 178 (6) 771-8

1995

Pagotto U, Arzberger T, Hopfner U, Sauer J, Renner U, Newton CJ, Lange M, Uhl E, Weindl A & Stalla GK
Expression and localization of endothelin-1 and endothelin receptors in human meningiomas. Evidence for a role in tumoral growth.
The Journal of clinical investigation, 1995 Oct, 96 (4) 2017-25

Pagotto U, Arzberger T, Hopfner U, Weindl A & Stalla GK
Cellular localization of endothelin receptor mRNAs (ETA and ETB) in brain tumors and normal human brain.
Journal of cardiovascular pharmacology, 1995, 26 Suppl 3 S104-6

1994

Arzberger T, Ritter E & Weindl A
Human facial nucleus: choline acetyltransferase and calcitonin gene-related peptide.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 1994 Dec, S403-6

Bufler J, Jahn K, Weindl A, Arzberger T & Hatt H
Patch-clamp study of membrane properties and GABA-activated currents of rat magnocellular supraoptic neurons in thin slice preparation.
Neurobiology (Budapest, Hungary), 1994, 2 (1) 5-20

1992

Weindl A, Bufler J, Winkler B, Arzberger T & Hatt H
Neurotransmitters and receptors in the subfornical organ. Immunohistochemical and electrophysiological evidence.
Progress in brain research, 1992, 91 261-9